Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
Alicen James, James A. Hendrixson, Ilham Kadhim, Adriana Marques-Carvalho, Jacob Laster, Julie Crawford, Jeff Thostenson, Visanu Wanchai, Amy Y. Sato, Intawat Nookaew, Jinhu Xiong, Maria Almeida, Melda Onal
Alicen James, James A. Hendrixson, Ilham Kadhim, Adriana Marques-Carvalho, Jacob Laster, Julie Crawford, Jeff Thostenson, Visanu Wanchai, Amy Y. Sato, Intawat Nookaew, Jinhu Xiong, Maria Almeida, Melda Onal
View: Text | PDF
Research Article Bone biology Cell biology

Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength

  • Text
  • PDF
Abstract

Autophagy is a recycling pathway in which damaged proteins, protein aggregates, and organelles are delivered to lysosomes for degradation. Autophagy insufficiency is thought to contribute to osteoporosis. Accordingly, autophagy elimination from the osteoblast lineage reduces bone formation and bone mass. However, whether increasing autophagy would benefit bone health is unknown. Here, we increased expression of endogenous transcription factor EB gene (Tfeb) in osteoblast lineage cells in vivo via CRISPR activation (TfebCRa mice). Elevated Tfeb stimulated autophagy and lysosomal biogenesis in osteoblasts. TfebCRa mice displayed a robust increase in femoral and vertebral cortical thickness at 4.5 months of age. Increases in cortical thickness were due to increased periosteal bone formation. Tfeb elevation also increased femoral trabecular bone volume. These changes increased bone strength of TfebCRa mice. Female TfebCRa mice displayed a progressive increase in bone mass and at 12 months of age had high cortical thickness and trabecular bone volume. Increased vertebral trabecular bone volume was due to elevated bone formation. Osteoblastic cultures showed that Tfeb elevation increased proliferation and mineral deposition. Overall, these results demonstrate TFEB-driven stimulation of autophagy in osteoblast lineage cells is associated with increased bone formation and strength and may represent an effective approach to combat osteoporosis.

Authors

Alicen James, James A. Hendrixson, Ilham Kadhim, Adriana Marques-Carvalho, Jacob Laster, Julie Crawford, Jeff Thostenson, Visanu Wanchai, Amy Y. Sato, Intawat Nookaew, Jinhu Xiong, Maria Almeida, Melda Onal

×

Figure 1

Elevation of Tfeb in osteoblast lineage cells via CRISPRa stimulates expression of genes involved in autophagy and lysosomal biogenesis.

Options: View larger image (or click on image) Download as PowerPoint
Elevation of Tfeb in osteoblast lineage cells via CRISPRa stimulates exp...
(A) Diagram depicting the chr17:47,736,921–47,737,191 of GRCm38/mm10 and showing positions of 5 sgRNAs in relation to the transcription start site (TSS) of Tfeb gene. To stimulate transcription of Tfeb, the SP-dCas9-VPR/sgRNA complex was targeted to within 150 bp of the TSS. (B) Gene expression analysis of osteoblastic UAMS-32 cells transfected with SP-dCas9-VPR and sgRNAs targeting Tfeb. n = 3 wells per group. P values are calculated by 1-way ANOVA followed by Dunnett’s multiple comparison test comparing each with the control group. (C) Transgene design of murine models used for CRISPRa. Specifically, CRISPR/dCas9-activator (CRa), Osx1-Cre, and sgRNATfeb mice were crossed to obtain triple transgenic CRa Osx1-Cre sgRNATfeb (TfebCRa) mice. (D and E) Comparison of Cre control mice, which include Osx1-Cre only (red dots), Osx1-Cre CRa (blue dots), and Osx1-Cre sgRNATfeb (gray dots), with TfebCRa mice. (D) Tfeb mRNA levels were measured in lumbar vertebrae 5 (spine) of TfebCRa mice and their littermate Cre controls by quantitative real-time PCR (qRT-PCR) at 2, 5, or 12 months of age. (E) mRNA levels of Tfeb and genes involved in lysosomal biogenesis and autophagy were measured in calvaria of 2-month-old TfebCRa mice and their Cre littermate controls via qRT-PCR. For all qRT-PCR analyses, mRNA levels were normalized to mouse Actb. Lysosome- and autophagy-related gene expression is represented as fold change over Cre controls. Lamp1, lysosomal-associated membrane protein 1. n = 6–18 mice per group. Bars indicate mean ± SD. *P < 0.05 as calculated by unpaired t test for equal or unequal variance.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts